These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 33706342)

  • 1. Buprenorphine Patch as a Bridge to Sublingual Treatment of Opioid Use Disorder in Pregnancy.
    Galati BM; Carter EB; Perez M; Russell S; Nazeer S; Raghuraman N; Kelly JC
    Obstet Gynecol; 2021 Apr; 137(4):713-716. PubMed ID: 33706342
    [No Abstract]   [Full Text] [Related]  

  • 2. A Retrospective Cohort Study of Obstetric Outcomes in Opioid-Dependent Women Treated with Implant Naltrexone, Oral Methadone or Sublingual Buprenorphine, and Non-Dependent Controls.
    Kelty E; Hulse G
    Drugs; 2017 Jul; 77(11):1199-1210. PubMed ID: 28536980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-adjusted plasma concentrations of sublingual buprenorphine are lower during than after pregnancy.
    Bastian JR; Chen H; Zhang H; Rothenberger S; Tarter R; English D; Venkataramanan R; Caritis SN
    Am J Obstet Gynecol; 2017 Jan; 216(1):64.e1-64.e7. PubMed ID: 27687214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buprenorphine treatment of pregnant opioid--dependent women: maternal and neonatal outcomes.
    Johnson RE; Jones HE; Jasinski DR; Svikis DS; Haug NA; Jansson LM; Kissin WB; Alpan G; Lantz ME; Cone EJ; Wilkins DG; Golden AS; Huggins GR; Lester BM
    Drug Alcohol Depend; 2001 Jun; 63(1):97-103. PubMed ID: 11297835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication-Assisted Treatment of Opioid Use Disorder in Adolescents and Young Adults.
    Cottrill CB; Matson SC
    Adolesc Med State Art Rev; 2014 Aug; 25(2):251-65. PubMed ID: 27132312
    [No Abstract]   [Full Text] [Related]  

  • 6. Home Induction of Buprenorphine for Treatment of Opioid Use Disorder in Pregnancy.
    Kelly JC; Raghuraman N; Stout MJ; Russell S; Perez M; Nazeer S; El Helou N; Zhang F; Carter E
    Obstet Gynecol; 2021 Oct; 138(4):655-659. PubMed ID: 34623078
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical treatment of opioid addiction and dependence.
    Ling W; Rawson RA; Compton M
    Methods Mol Med; 2003; 84():285-95. PubMed ID: 12703332
    [No Abstract]   [Full Text] [Related]  

  • 8. Buprenorphine for postoperative pain following general surgery in a buprenorphine-maintained patient.
    Book SW; Myrick H; Malcolm R; Strain EC
    Am J Psychiatry; 2007 Jun; 164(6):979. PubMed ID: 17541066
    [No Abstract]   [Full Text] [Related]  

  • 9. [Substitution therapy with buprenorphine to pregnant women with opioid dependency].
    Olofsson MJ; Ege PP
    Ugeskr Laeger; 2003 Sep; 165(38):3605. PubMed ID: 14556389
    [No Abstract]   [Full Text] [Related]  

  • 10. 23-year-old woman being treated for opioid dependence, unexpected weight gain.
    Chudgar NP; Greenblatt L
    J Fam Pract; 2014 Jul; 63(7):366-7. PubMed ID: 25198209
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers.
    Strain EC; Stoller K; Walsh SL; Bigelow GE
    Psychopharmacology (Berl); 2000 Mar; 148(4):374-83. PubMed ID: 10928310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Buprenorphine as opioid substitution to pregnant addicts].
    Rasmussen ET; Nielsen LB
    Ugeskr Laeger; 2003 Sep; 165(38):3607-8. PubMed ID: 14556390
    [No Abstract]   [Full Text] [Related]  

  • 13. Buprenorphine: an alternative to methadone.
    Med Lett Drugs Ther; 2003 Feb; 45(1150):13-5. PubMed ID: 12592214
    [No Abstract]   [Full Text] [Related]  

  • 14. Transdermal buprenorphine patch: Potential for role in management of opioid dependence.
    Dhawan A; Modak T; Sarkar S
    Asian J Psychiatr; 2019 Feb; 40():88-91. PubMed ID: 30772733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naltrexone in the treatment of opioid-dependent pregnant women: common ground.
    Jones HE; Chisolm MS; Jansson LM; Terplan M
    Addiction; 2013 Feb; 108(2):255-6. PubMed ID: 23331881
    [No Abstract]   [Full Text] [Related]  

  • 16. Opioid detoxification via single 7-day application of a buprenorphine transdermal patch: an open-label evaluation.
    Lanier RK; Umbricht A; Harrison JA; Nuwayser ES; Bigelow GE
    Psychopharmacology (Berl); 2008 Jun; 198(2):149-58. PubMed ID: 18327673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Food and Drug Administration approval of sustained-release buprenorphine for treatment of opioid dependence: realizing its potential.
    Sigmon SC; Bigelow GE
    Addiction; 2017 Mar; 112(3):386-387. PubMed ID: 27561982
    [No Abstract]   [Full Text] [Related]  

  • 18. Buprenorphine: a potential new treatment option for opioid dependence.
    Srivastava A; Kahan M
    CMAJ; 2006 Jun; 174(13):1835. PubMed ID: 16785455
    [No Abstract]   [Full Text] [Related]  

  • 19. In brief: Buprenorphine/naloxone (Zubsolv) for opioid dependence.
    Med Lett Drugs Ther; 2013 Oct; 55(1427):83. PubMed ID: 24129113
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and safety of a sublingual buprenorphine/naloxone rapidly dissolving tablet for the treatment of adults with opioid dependence: A randomized trial.
    Webster L; Hjelmström P; Sumner M; Gunderson EW
    J Addict Dis; 2016; 35(4):325-338. PubMed ID: 27267785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.